myelodysplast syndrome md heterogen group hematolog align consider variable prognosis rural hematopoiet cell transplant hit studi compare outcome sil until cord blood ucb donor exist use universe minnesota marrow transplant but database retrospect analyze among patient undergo either double observe similar survive recaps nonrelaps mortal donor source increase monsoon karyotyp p reduce intent conduit summary data highlight regardless source support use alter naval 